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The envelope of hepatitis B virus (HBV), containing the L, M, and S proteins, is essential for virus entry and maturation. For direct
visualization of HBV, we determined whether envelope assembly could accommodate the green fluorescent protein (GFP). While the C-
terminal addition of GFP to S trans-dominant negatively inhibited empty envelope particle secretion, the N-terminal GFP fusion to S (GFP.S)
was co-integrated into the envelope, giving rise to fluorescent particles. Microscopy and topogenesis analyses demonstrated that the proper
intracellular distribution and folding of GFP.S, required for particle export were rescued by interprotein interactions with wild-type S.
Thereby, a dual location of GFP, inside and outside the envelope, was observed. GFP.S was also efficiently packaged into the viral envelope,
and these GFP-tagged virions retained the capacity for attachment to HBV receptor-positive cells in vitro. Together, GFP-tagged virions
should be suitable to monitor HBV uptake and egress in live hepatocytes.
D 2004 Elsevier Inc. All rights reserved.
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Hepatitis B virus (HBV), a human hepadnavirus, is an
enveloped DNA virus that infects hepatocytes and causes
acute and chronic liver disease. Despite considerable
understanding of the details of hepadnaviral genome
replication, fundamental insights into the early and late
steps of an HBV infection are still lacking. Infection initiates
by virus attachment to the hepatocyte and is determined by
the HBV envelope. Among the three related large L, middle
M, and small S envelope proteins, L has been shown to play
the key role in receptor recognition and cell attachment (Le
Seyec et al., 1999; Neurath et al., 1986). The route of
subsequent HBV uptake is a yet poorly identified process
and may proceed by direct fusion of the viral envelope with0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: prange@mail.uni-mainz.de (R. Prange).the plasma membrane, receptor-mediated endocytosis, or
alternate mechanisms (for review, see Cooper et al., 2003).
In favor of a fusion mechanism at the cell surface is the
previous demonstration of a pH-independent internalization
of HBV in primary human hepatocytes (Hagelstein et al.,
1997). By contrast, infectivity studies performed with the
related duck HBV in duck liver cells have demonstrated that
viral entry depends on endocytosis (Breiner et al., 1998).
In the late stages of an HBV infection, progeny virions
are formed by budding of the pre-assembled cytosolic
nucleocapsids, enclosing the partially double-stranded DNA
genome 3.2 kb in length and the viral polymerase through
intracellular membranes accommodating the viral envelope
proteins (for review, see Nassal, 1996). During this process,
an excess of envelope proteins is not incorporated into
virion envelopes but self-assembles into secreted subviral
lipoprotein particles referred to as hepatitis B surface
antigen (HBsAg) particles or empty envelopes. These
particles have been shown to mature by budding into
intralumenal cisternae of post-endoplasmic reticulum (ER)–04) 158–167
Fig. 1. The N-terminal GFP.S fusion is co-secreted with wild-type S. (A)
Schematic representation of the HBV S protein and the GFP.S and S.YFP
fusion constructs. Numbers below the domains refer to the corresponding
amino acid positions of S (hatched bar) and GFP/YFP (white bars). For
GFP.S, the two domains are linked by the amino acid sequence
SGLRSRAQASN and terminated by the extra sequence WDPPDLDN,
while S and YFP are interspersed by the sequence DPPVAT. (B) Synthesis,
C. Lambert et al. / Virology 330 (2004) 158–167 159pre-medial-Golgi compartments and to exit the cell by the
constitutive secretory pathway (Huovila et al., 1992). In
contrast, the intracellular budding site of viral particles has
not been defined to date.
The three L, M, and S envelope proteins contribute
differently to subviral and viral particle formation. Assem-
bly and secretion of subviral particles are solely driven by
the S protein and are initiated by co-translational integration
of S molecules into the ER membrane (Simon et al., 1988).
The current models for the transmembrane structure of S
assume a lumenal disposition (i.e., external in the mature
particles) of both the N- and C-termini and four membrane-
spanning segments (Berting et al., 1995; Stirk et al., 1992).
Following dimerization, about 100 transmembrane S mono-
mers then self-assemble with host-derived lipids into
spherical empty envelopes, 20 nm in diameter, which are
secreted from the infected liver and transfected cell lines
with high efficiency. This process is also sustained by the M
protein that shares the sequence of S but differs in its N-
terminal preS2 extension. By contrast, the L protein along
with its N-terminal preS1 plus preS2 domains blocks
subviral particle production but is the key player in virion
formation (Bruss and Ganem, 1991; Chisari et al., 1986).
The pivotal role of the L protein in the viral life cycle is
related to its dual transmembrane topology (Bruss et al.,
1994; Ostapchuk et al., 1994; Prange and Streeck, 1995), as
its internal (cytosolic) preS domain is needed for envelop-
ment of cytosolic nucleocapsids (Bruss et al., 1996), while
the same external (lumenal) preS domain mediates receptor
binding during host cell attachment (Le Seyec et al., 1999).
In the present study, we addressed whether the HBV
envelope could be tagged with the green fluorescent protein
(GFP) without impairing its functionality. We reasoned that
such GFP-tagged particles should be a promising tool to
study the early and late stages of the HBV life cycle in live
cells.glycosylation, and secretion of SHA and the fusion constructs. Lysates (C)
from transfected COS-7 cells were divided into two portions and either left
mock treated or digested with PNGase F, as indicated. Cellular supernatants
(M) were analyzed without enzymatic de-glycosylation. Proteins were
processed by SDS-PAGE and HA-specific (lanes 1–3) or GFP-specific
(lanes 4–9) immunoblotting. Nonglycosylated (p) and glycosylated (gp)
forms are indicated on the left with the numbers referring to the molecular
masses of the polypeptides. (C) Secretion of GFP.S is rescued by co-
expressed wild-type S molecules. Supernatants of cells synthesizing GFP.S
in the absence () or presence (+) of S were assayed by GFP-specific
Western blotting.Results
N-terminal but not C-terminal addition of GFP to S allows
co-integration into empty envelopes
For tagging of the HBVenvelope with GFP, the S protein
was chosen as the target because this protein is an essential
and abundant constituent of the virion envelope. Two
chimeras were constructed by fusing either a fluorescence-
enhanced GFP in frame to the N-terminus of S (GFP.S) or
the yellow-shifted YFP variant to the C-terminus of S
(S.YFP) (Fig. 1A). The fusion constructs were transiently
expressed in COS-7 cells and analyzed by GFP-specific
Western blotting. The unfused S protein with a C-terminal
HA-tag (SHA) was included as reference. As shown in Fig.
1B, lysates of cells contained SHA in its characteristic
doublet of a non-glycosylated (p24) and single-glycosylated
(gp27) form as a consequence of partial modification atAsn-146. N-linked glycosylation was confirmed by treat-
ment with peptide/N-glycosidase F (PNGase F), which
converted the gp27 form of S to its faster migrating p24
form. The GFP.S and S.YFP fusion proteins were stably
expressed as 51-kDa polypeptides in accordance with the
molecular masses calculated for their non-glycosylated
forms (p51) (Fig. 1B). As evidenced by enzymatic de-
glycosylation, both fusion proteins appeared in glycosylated
forms (gp54) in addition, indicating that they were
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into the ER lumen. However, unlike wild-type SHA, each
chimera failed to be secreted from transfected cells into the
supernatants (Fig. 1B).
Although these results implicated some misfolding of
GFP.S and S.YFP, we nonetheless assessed whether their
block to secretion could be abrogated by co-expression of
wild-type S. COS-7 cells were co-transfected with each
fusion construct, and the wild-type vector at a ratio of 1:1
and cellular supernatants were assayed by GFP-specific
immunoblotting. The S.YFP fusion turned out to act in a
trans-dominant-negative manner and even inhibited export
of co-expressed wt S chains (data not shown). By contrast,
GFP.S was secreted in the presence of S (Fig. 1C), and thus
was chosen for further analysis. For quantitative evaluation
of the secretion efficacy of GFP.S, lysates and supernatants
of GPF.S + S co-transfected cells were analyzed with a
GFP-specific ELISA. This determination revealed that 68 F
5.2% of the intracellular GFP.S was released into the
supernatant when co-expressed with wt S.
GFP.S localizes to the ER if co-expressed with wild-type S
In order to get insights how S rescued the secretion of
GFP.S, we comparatively examined the intracellular distri-
bution of GFP.S in the presence and absence of SHA. When
expressed alone, GFP.S surprisingly yielded an intense
micropunctate fluorescence (Fig. 2a). These bdotsQ partially
overlapped with ER structures, as shown by co-staining ofFig. 2. GFP.S co-localizes with wild-type S at the ER. Shown is the intracellular
SHA (squares d–i) in COS-7 cells. Cells were fixed, permeabilized, and examined b
immunostaining with a mouse antibody to PDI followed by AlexaFluor 494-conju
antibody followed by AlexaFluor 494-conjugated goat anti-mouse IgG (red) to vis
overlapping red and green signals appear yellow.the cells with antibodies to the ER-resident protein disulfide
isomerase (PDI) (Figs. 2b and c). Although the nature of
these structures remained to be determined, they might
present aggregates of malfolded GFP.S destined for degra-
dation. Importantly, however, on co-expression of GFP.S
with SHA, the chimera now exhibited a widely dispersed
membranous staining pattern together with a significant co-
localization with the ER marker PDI (Figs. 2d–f). Under the
same conditions, a nearly 100% co-localization of GFP.S
with SHA was observed when cells were stained with HA-
specific antibodies (Figs. 2g–i). From these data we
concluded that the correct distribution of GFP.S, required
for export, was warranted by interaction with co-expressed
S chains.
Incorporation of GFP.S into envelopes produces fluorescent
subviral particles
To determine whether the co-secreted GFP.S and SHA
proteins resembled authentic subviral HBV envelope par-
ticles, the culture supernatant of transfected cells was
fractionated by isopycnic CsCl gradient centrifugation and
fractions were analyzed by an S-specific ELISA. As shown
in Fig. 3A, the co-secreted proteins banded at a buoyant
density of about 1.22 g/ml, typical for wild-type S
lipoprotein particles (Heermann and Gerlich, 1991). Peak
fractions were then subjected to specific Western blot
analysis that confirmed the presence of both the GFP.S
fusion and the SHA protein (Fig. 3A). In addition, whendistribution of GFP.S expressed either alone (squares a–c) or together with
y fluorescence microscopy. (a, d, and g) GFP fluorescence (green); (b and e)
gated goat anti-mouse IgG (red); (h) immunostaining with a mouse anti-HA
ualize SHA. Squares c, f, and i are the corresponding merged images so that
Fig. 3. Co-assembly of GFP.S and wild-type S into fluorescent lipoprotein particles. (A) Concentrated cell culture media of GFP.S + SHA co-transfected cells
were analyzed by CsCl density centrifugation. Gradients were fractionated from the top and each fraction was assayed for HBsAg by ELISA (-.-). The peak
fractions 7–10 were subjected to SDS-PAGE; the upper part of the blot was reacted with a-GFP, the lower part with a-HA antibodies. (B) For velocity
sedimentation analysis, concentrated supernatants of SHA (-n-) or GFP.S + SHA (-.-)-transfected cells were assayed by sucrose gradient centrifugation. After
fractionation from the bottom, fractions were probed for HBsAg particles by ELISA. (C) Autofluorescence of GFP.S + SHA particles. Supernatants of co-
transfected cells were concentrated 50-fold by centrifugation through a 20% sucrose cushion. Pelleted particles were spotted on glass bottom dishes, visualized
by fluorescence microscopy, and photographed at 1600 magnification. Scale bar = 5 Am.
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by sucrose gradient velocity centrifugation, their sedimen-
tation profiles were nearly coincident with a buoyant density
of about 1.130 g/ml in sucrose (Fig. 3B). Together, these
data demonstrated that GFP.S was successfully incorporated
into subviral particles that closely resembled S spheres with
respect to density and size.
Because the fluorescence of GFP depends on its native
three-dimensional structure that might be altered within the
chimeric context, we next examined whether purified GFP.S
+ SHA particles were fluorescent. As imaged by fluores-
cence microscopy, a strong vesicular GFP staining was
observed, indicating a native display of GFP within the
particle (Fig. 3C). The intensity of fluorescence and hence
the apparent size of the particles appeared slightly variable
and brighter than expected, perhaps because of some
particle aggregation or variation in the amount of GFP.S
incorporation.
GFP.S forms a split topology if co-expressed with
wild-type S
The production of fluorescent subviral particles indicated
that the individual constituents of the GFP.S chimeric
protein were properly folded, at least when co-expressed
with wild-type S chains. Nonetheless, for further studies
outlined below, it was important to know its precise
topology, that is, the orientation of the GFP domain relative
to the membrane. According to current models for the
transmembrane structure of S, its N-terminus and hence theGFP fusion site are located to the lumenal side of
intracellular membranes that is topologically equivalent to
the virion surface (Fig. 4A) (Berting et al., 1995; Stirk et al.,
1992). To analyze the topological features of GFP.S,
expressed in the absence or presence of S molecules, we
used proteinase K protection experiments of microsomes
prepared from transfected COS-7 cells. Both GFP.S and S
proteins were synthesized in HA-tagged form to enable their
simultaneous detection by immunoblotting. Consistent with
previous works (Wunderlich and Bruss, 1996), proteinase K
did not cleave the p24/gp27 forms of SHA unless the
protecting microsomal membrane was disrupted by deter-
gent (Fig. 4B, lanes 4–6). By contrast, GFP.SHA synthe-
sized in the absence of SHA chains was accessible to
cleavage with the protease in intact microsomes (Fig. 4B,
lanes 1–3). Thereby, two HA-reactive fragments were
generated that closely resembled the full-length p24 and
gp27 forms of SHA. Therefore, cleavage of GFP.SHA must
have occurred at least at a very distal site within the N-
terminal fused GFP domain. In support of a fully
cytoplasmic location of the GFP domain, we were unable
to detect GFP-reactive proteolysis products by Western
blotting (data not shown). When expressed together with
SHA, the topology of GFP.SHA surprisingly changed in
such that a fraction of polypeptides was now protected from
cleavage with proteinase K by the microsomal membrane
(Fig. 4B, lanes 4–6). These results indicated that the
presence of extra SHA chains caused a partial topological
change of the N-terminal GFP domain from cytosolic to
lumenal, likely as a consequence of GFP.SHA/SHA
Fig. 4. GFP.S forms a mixed topology when co-expressed with wild-type S.
(A) Model of the transmembrane topology of S at the ER membrane and the
virion envelope. The predicted four membrane spanning segments of S
project its N- and C-terminus into the ER lumen that is topologically
equivalent to the virus outside. The N-glycosylation site at Asn-146 is
indicated by w. (B.) Proteinase K protection assay of GFP.S. COS-7 cells
were transfected with HA-tagged GFP.S either alone (lanes 1–3) or together
with HA-tagged S (lanes 4–6) or the secretion-defective SDTM1 mutant
(lanes 7–9). Two days after transfection, microsomes were prepared and
either left untreated or digested with Proteinase K (Prot. K) in the absence
() or presence (+) of NP-40, as denoted above each lane. Samples were
analyzed by HA-specific immunoblotting. The GFP.S- and S-specific p and
gp forms are indicated on the left; the corresponding forms of SDTM1HA
are denoted on the right.
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between partial N-tail translocation and secretion compe-
tence and vice versa, we finally investigated the topological
properties of GFP.SHA complemented in trans with a
secretion-defective S mutant protein. To this aim, we took
advantage of SDTM1HA that lacks the first transmembrane
domain and is blocked in the assembly and secretion of
subviral particles (Prange et al., 1992). Consistent with our
previous results (Prange et al., 1992), the deletion mutant
predominantly appeared in a glycosylated 24-kDa form
(gp24; Fig. 4B, lane 7). Importantly, SDTM1HA failed to
impart a partial lumenal orientation of GFP.SHA (Fig. 4B,
lanes 7–9). Together, these data indicated that the topo-
logical change of GFP.SHA in the presence of extra S
molecules was likely established during the formation and
extracellular release of the GFP.SHA/SHA mosaic particles.
If this notion was correct, we would expect the GFP tag
located outside and inside of the secreted particle. For a
formal proof of a surface display of the GFP domain, we
tried to immunoprecipitate the particles under non-denatur-
ing conditions using two monoclonal a-GFP antibodies
directed against different epitopes. However, neither anti-
body brought down the particles in the absence of detergent(data not shown; and see below). Although these results
might argue against an exterior location of GFP, it seemed
equally possible that the epitopes were not accessible in the
bulky beta barrel of GFP on the intact particle.
Incorporation of GFP.S into envelopes allows viral particle
formation
Next we examined whether GFP.S would also be
incorporated into the viral envelope. For virus production,
human hepatoma HuH-7 cells were transiently transfected
with a cloned over-length copy of the HBV genome. On co-
transfection with the GFP.S expression plasmid at a 1:1
ratio, virus secretion into the cellular supernatant was
reduced about 3-fold (data not shown), whereas no
inhibitory effect of GFP.S on the virus secretion profile
was observed if a 4-fold excess of the HBV encoding vector
was used for co-transfection. Because transfected HuH-7
cells released viral and subviral particles into the culture
medium, virions were separated from empty envelope
particles by isopycnic CsCl gradient centrifugation. A
resolution of these particle types was verified by assaying
of fractions for the presence of HBV DNA by the
endogenous polymerase reaction. As shown in Fig. 5 (A
and B), DNA-containing virions banded at a density near
1.24 g/ml around fractions 18–22, with the strongest signal
in fraction 20, while empty envelopes were found at their
typical density of 1.22 g/ml. Importantly, when probed with
a GFP-specific ELISA, the virus-containing fractions were
clearly reactive, thus giving first hints to an incorporation of
the GFP-tagged S protein during virus assembly. As a final
proof, supernatants of HBV + GFP.S co-transfected HuH-7
cells were immunoprecipitated with a GFP-specific anti-
body prior to detection of the viral genome by dot-blot
analysis. For reasons mentioned above, such a precipitation,
however, required the presence of detergent (0.5% NP-40)
that decreased the limits of detection, likely because some
nucleocapsids might leak from the disordered envelope
network. Nonetheless, despite these restraints, we could
specifically detect the viral DNA in a-GFP-precipitated
supernatants (Fig. 5C).
Incorporation of GFP.S into envelopes allows virus
attachment to liver cells
To investigate whether these fluorescent HBV virions
supported attachment to hepatocytes, cell binding assays
were performed. Although most permanent cell lines are not
permissive to HBV infection, the human hepatoblastoma
HepG2 cell line is able to bind the virion (Lu et al., 1996).
For binding, we applied the same assay conditions as
validated previously for in vitro infection of primary human
hepatocytes (Gripon et al., 1993). Accordingly, recombinant
HBV + S.GFP particles secreted from co-transfected HuH-7
cells (see above) were precipitated with polyethylene glycol
(PEG) and reacted with HepG2 cells grown on glass bottom
Fig. 5. GFP.S is incorporated into the virus envelope. (A) Viral and subviral
particles secreted from HBV + GFP.S co-transfected HuH-7 cells were
separated by isopycnic CsCl gradient centrifugation according to their
buoyant densities (-E-). Fractions were analyzed by enzyme immuno-
assays for HBsAg (-n-) and GFP (-.-), as indicated. (B) Fractions 18–22
containing virion particles were further subjected to an envelope-specific
immunoprecipitation and radioactive labeling of the viral genome by the
endogenous viral polymerase. The migration of the HBV DNA genome as
visualized by agarose electrophoresis and PhosphorImaging is indicated.
(C) Pooled extracellular viral particle fractions from HBV + GFP.S co-
transfected cells were immunoprecipitated with either an envelope-specific
(a-HBsAg) or a GFP-specific (a-GFP) antibody prior to extraction of the
viral genome and DNA dot blot analysis. For control of nonspecific
immunoprecipitation, native HBV particles (control) were reacted with the
a-GFP MAb (third panel from the left). In addition, the control material
was probed with a-HBsAg, as shown in the right panel.
Fig. 6. GFP-tagged HBV binds to HepG2 cells. In squares a and b are
shown the adsorption of GFP-tagged HBV particles (HBV + GFP.S) to live
HepG2 cells, grown on glass bottom dishes, as detected by GFP
autofluorescence (magnification, 1600). Under the same assay con-
ditions, GFP-tagged subviral particles (S + GFP.S) did not bind to cells
(squares c and d).
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several washes, a strong GFP fluorescence almost evenly
distributed on the plasma membrane of the hepatocytes was
observed (Figs. 6a and b). To test the specificity of
adsorption, we analyzed the binding properties of GFP.S +
S subviral particles that lacked the L envelope protein and
thus the receptor binding site. As expected, these particles
failed to attach to HepG2 cells thereby yielding only some
diffuse background staining (Figs. 6c and d). However,
because infected liver cells and HBV-producing cell lines
are known to also produce subviral particles containing the
L protein (Nassal, 1996), we could not totally exclude thepossibility that the GFP fluorescence, shown in Figs. 6a and
b, might be also generated by binding of this particle type.Discussion
In recent years, the adaptation of the Aequorea Victoria
GFP for visualization of protein expression and protein
localization in living organisms has provided a powerful
new tool. Here we applied this approach to hepatitis B virus
and obtained fluorescent subviral and viral particles by
incorporation of the viral S envelope protein, tagged with
GFP, in trans, thereby preserving all the functions necessary
for the viral life cycle.
Because HBV empty envelope particles, built from the S
protein, provide a safe antigen delivery system, their use as
a carrier for the presentation of various antigens is a long
established practice. To date, chimeric particles have been
produced in mammalian cells with inserts in the range of
10–80 amino acids (Delpeyroux et al., 1986; Michel et al.,
1988; Prange et al., 1995). For example, the N-terminal
ectodomain of the S protein has been shown to tolerate 84
foreign residues while its C-terminus accommodated 42
residues without effects on particle assembly and secretion
(Michel et al., 1988; Prange et al., 1995). In agreement and
extension, the current study demonstrated that the N-
terminus of S is more permissive for insertions than the
C-terminus and is even amenable for addition of the
complete GFP protein. Hence, proteins of at least up to
238 amino acids can be displayed on HBV envelope
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as a carrier system.
Particle formation of the GFP.S chimeric protein, how-
ever, depended on the presence of the wild-type S protein,
indicating that the fusion construct itself failed to fold into a
functional conformation required for assembly. Nonetheless,
as judged by the autofluorescence of GFP.S in cells, at least
the GFP-tag must have folded properly. Thereby, GFP.S
surprisingly appeared in sequestered speckles that over-
lapped with the ER compartment. The formation of similar
structures, termed concentric membranous ER bodies, has
been recently observed upon expression of a misfolded
mutant of the cystic fibrosis transmembrane conductance
regulator that accumulates in these bodies prior to ER-
associated degradation (Okiyoneda et al., 2004). Accord-
ingly, the S moiety of GFP.S might not attain its native
transmembrane structure thereby tending to aggregate into
discrete speckles. On co-expression with wild-type S, the
intracellular distribution of GFP.S completely changed in
such that it now yielded a typical membranous ER staining
pattern and a high degree of co-localization with S. This
result indicates that the proper folding and localization of
GFP.S were warranted by interprotein interactions with wild-
type S chains. As a consequence thereof, highly fluorescent
mosaic particles were formed and secreted, which closely
resembled authentic spherical S lipoprotein particles accord-
ing to density and size.
Furthermore, the GFP.S fusion protein could be also
natively incorporated into the virion envelope. GFP, by
virtue of its properties, has been successfully used to tag
various viruses like, for example, herpes simplex virus type
I, vesicular stomatitis virus, vaccinia virus, HIV, and mouse
hepatitis coronavirus (Bosch et al., 2004; Dalton and Rose,
2001; Desai and Person, 1998; Stauber et al., 1999; Ward
and Moss, 2001). However, unlike these viruses, HBV is a
very small particle with a diameter of 42 nm and a dense
packed structure. Even so, it can apparently accommodate
multiple copies of GFP, indicating that there is substantial
space available between the viral envelope and the
nucleocapsid as well as sufficient flexibility allowing the
incorporation of proteins in trans. Although we were unable
to unequivocally define the location of the GFP-tag within
the secreted HBV envelope, our topological analysis of
GFP.S suggested an interior (i.e., cytosolic side of micro-
somes) and exterior (i.e., lumenal side of microsomes)
display of GFP. The formation of such a mixed topology is
rare among membrane proteins but is a prominent feature of
the large L envelope protein of HBV (Bruss et al., 1994;
Ostapchuk et al., 1994; Prange and Streeck, 1995). In that
case, it is established post-translationally at the ER
membrane and is uncoupled from envelope assembly
(Lambert and Prange, 2001). By contrast, the two differently
orientated isoforms of GFP.S were only generated upon co-
expression with secretion-competent wild-type S molecules,
thus hinting to a link between envelope subunit interactions
and topogenesis of GFP.S. While the underlying mechanismremains to be determined, it is tempting to speculate that the
dual location of the GFP domain might be beneficial for the
functionality of GFP-tagged HBV. By splitting the tag to
both sides of the virion envelope, the local density of GFP
might be lowered thereby limiting the risk of sterical
hindrance of the envelope/nucleocapsid interactions at the
interior and the envelope/receptor binding at the exterior.
By using HepG2 cells, an established hepatocyte-derived
cell line that is permissive for HBV attachment but non-
permissive to a productive infection (Lu et al., 1996), a
specific binding of GFP-tagged viral particles was observed.
Hence, these particles must imitate the natural virus and
viral attachment appeared to proceed through the authentic
pathway. However, whether these particles even retained
their infectivity remains to be addressed. In vitro HBV
infection studies had been restricted to primary human
hepatocytes that are not readily available. More recently,
however, successful experimental infections of tree shrews
were carried out that might present a new animal model
(Ko¨ck et al., 2001). In addition, a human hepatoma cell line
has been established that supports HBV infection (Gripon et
al., 2002). Therefore, the GFP-tagged HBV envelope might
be useful for the investigation of the early events of virus
penetration such as monitoring entry and uncoating in living
infected cells and tracing the fate of the envelope structure.
With GFP as a marker, it should also be possible to
approach sites of viral assembly and to follow the intra-
cellular trafficking and egress of (sub)viral particles during
the late stages of an HBV infection.Materials and methods
Plasmid constructions
The mammalian expression vectors carrying the HBV S
gene with or without a C-terminally tagged influenza virus
hemagglutinin (HA) epitope under the control of the human
metallothionein IIA promoter had been described (pNI2.-
SHA and pNI2.S, respectively) (Hartmann-Stu¨hler and
Prange, 2001). For construction of the GFP.S chimera,
plasmid pEGFP-C1 (BD Biosciences Clontech) was cut
within the multiple cloning site by using EcoRI and SmaI.
To introduce an EcoRI restriction site downstream of the
start codon of the HBV S gene, site-directed mutagenesis
with a recombinant M13mp19 bacteriophage carrying a 2.3-
kb BglII–BglII fragment (nucleotide [nts] 2839 to 1986, as
referred of the HBV genome, subtype ayw) with the anti-
sense oligonucleotide 5V-GAATCCTGAATTCATGTTCTC-
3V (the EcoRI site is italic) was performed. The newly
created EcoRI site, cutting between codon positions 4 and 5
(nts 170) of the S gene, together with the cognate filled-in
AccI site (nts 827) was then used to generate an S encoding
fragment for in-frame insertion into pEGFP-C1, giving rise
to plasmid pEGFP.S. In parallel, the HA-tagged version of
the S gene was similarly cloned, giving rise to GFP.SHA. A
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linearly fused to the C-terminus of S (S.YFP), was created
using plasmid pEYFP-N1 (BD Biosciences Clontech),
which was opened with XhoI and BamHI. The HA-tagged
S gene was derived from pNI2.SHA by cleavage with XhoI
(nts 127) and PsiI (cutting between the HA-tag and the
translational stop codon) and inserted into pEYFP-N1 after
filling-in of its BamHI site. Plasmid pNI2.SDTM1HA
carries an in-frame deletion of TM1 that was achieved by
removal of a StyI (nts 180)–XbaI (nts 249) fragment from
pNI2.S.
Cell culture, transfection, and immunoblotting
To produce viral envelope proteins, transient transfection
of COS-7 cells by electroporation was used. Unless
otherwise indicated, 5  106 cells were transfected with
12 Ag of plasmid DNA, while in the case of co-trans-
fections, 12 Ag of each DNA was used. Three days post-
transfection, cellular supernatants were harvested and
clarified by low-speed centrifugation. Cells were washed
twice in Tris-buffered saline (TBS, 50 mM Tris–Cl [pH 7.5],
150 mM NaCl) and lysed with 1 ml of TBS–0.5% Nonidet
P-40 (NP-40), supplemented with a protease inhibitor
cocktail (Roche), for 30 min on ice. After centrifugation
for 5 min at 13000  g and 4 8C, proteins of lysates and cell
supernatants were precipitated with 10% trichloroacetic acid
(TCA), washed twice with 5% TCA, and once with acetone.
TCA precipitates were resolved by SDS-PAGE and Western
blotted to nitrocellulose membranes. Enzymatic N-de-
glycosylation of proteins with PNGase F (New England
Biolabs) was done according to the instructions of the
supplier. Immunoblots were incubated with a mouse
monoclonal antibody (MAb) against the HA epitope
(BabCO), diluted 1:2000 in blotting buffer (PBS with 5%
skim milk) or a mouse MAb specific for GFP (JL-8; BD
Biosciences Clontech) applied in 1:4000 dilution. Perox-
idase-labeled secondary antibodies (Dianova) were diluted
as instructed by the manufacturer, and the blots were
developed with enhanced chemiluminescence detection
reagents (Amersham Biosciences).
Immunoassays
In parallel, cell lysates and supernatants were analyzed
by ELISAs. HBsAg was measured using the Auszyme II
diagnostic kit (Abbott Laboratories). For simultaneous
detection of GFP and HBsAg, a sandwich ELISA with
GFP-specific antibodies in the solid phase and S-specific
antibodies in the detection phase was employed. Briefly, the
a-GFP-MAb JL-8 was coated to microtiter plates (1:500
dilution in TBS) for 3 h at room temperature. Nonspecific
binding sites were blocked with TBS–1% bovine serum
albumin for 18 h at 4 8C, followed by three washes with
TBS–0.1% Tween 20. Samples were reacted for 2 h at 37 8C
in the presence of 0.5% NP-40, washed out, and incubatedwith peroxidase-labeled HBsAg-specific MAbs (Auszyme
II) for 1 h at 37 8C.
GFP fluorescence and immunofluorescence assays
Transfected COS-7 cells on glass cover-slips were fixed
and permeabilized with ice-cold methanol containing 2 mM
EGTA for 15 min at 20 8C. For staining of internal
antigens, cells were incubated with the HA-specific MAb
(1:200 dilution in PBS) or a mouse MAb specific for
protein disulfide isomerase (SPA-891, StressGen Biotech-
nologies) (1:2000 dilution in PBS) prior to incubation with
an AlexaFluor 594-conjugated goat anti-mouse immuno-
globulin G (2 Ag/ml in PBS; Molecular Probes). Sponta-
neous GFP fluorescence and immunostaining were
visualized with a fluorescence microscope (Axiovert
200M, Zeiss), and images obtained with a Zeiss AxioCam
digital camera were processed using the Zeiss Axiovision
software. To assess for fluorescent particles, cellular super-
natants were concentrated 50-fold by ultracentrifugation
(see below). A 10-Al aliquot was spotted on glass bottom
dishes (BD Biosciences), briefly air dried, and imaged with
a 100 objective.
Proteinase K protection assay
Three days after transfection of COS-7 cells, micro-
somes were prepared essentially as described (Prange and
Streeck, 1995). Briefly, cells were disrupted by dounce
homogenization, and microsomes were recovered by
ultracentrifugation prior to proteolysis with proteinase K
(100 Ag/ml) in the presence or absence of 0.5% NP-40.
After incubation on ice for 60 min, proteinase K was
inactivated by the addition of 10 Al/ml phenylmethylsul-
fonyl fluoride. Each sample was then adjusted to 0.5% NP-
40 and solubilized for 20 min on ice. Cleared samples
were precipitated with 10% TCA and subjected to Western
blot analysis.
Cesium chloride and sucrose gradient purification of
particles
Subviral particles of cellular supernatants were pelleted
through a 1-ml cushion of 20% sucrose in TNE (10 mM
Tris–CL [pH 7.5], 150 mM NaCl, 10 mM EDTA) using a
SW 40 rotor (Beckman) at 37000 rpm for 4 h at 4 8C. The
resuspended pellets were separated by isopycnic gradient
centrifugation through 10–50% (wt/vol) cesium chloride in
TNE. After centrifugation at 35000 rpm and 10 8C (SW 40
rotor), fractions were collected from the top and screened for
chimeric particles by ELISA, immunoblotting, and fluo-
rescence analysis. For velocity sedimentation, pelleted
particles were layered on top of a 12-ml linear sucrose
gradient (10 to 50% [wt/wt] sucrose in TNE buffer) with a
68% sucrose cushion, centrifuged at 35000 rpm and 10 8C
for 16 h (SW 40 rotor), and processed as above.
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For replication of HBV in the HuH-7 liver cell line,
plasmid pHBV was used that carries a 1.1 mer of the HBV
DNA genome (Radziwill et al., 1990). This plasmid was co-
transfected with pEGFP.S by the calcium phosphate
precipitation technique. Four days after transfection, extrac-
ellular virions were separated from subviral empty enve-
lopes and non-enveloped core particles by isopycnic CsCl
gradient centrifugation. To this aim, 3.8 g of CsCl was
dissolved in 10 ml cleared supernatant and 28 ml of this
solution was spun for 20 h at 45000 rpm at 10 8C in a
Beckman 50vTi rotor. Fractions were collected from the
bottom, supplemented with the protease inhibitor cocktail,
and were screened for HBsAg and GFP by immunoassays.
Following dialysis of fractions against 10 mM Tris–CL [pH
7.5], 150 mM NaCl at 4 8C, virions were isolated by an
envelope-specific immunoprecipitation, as described previ-
ously (Lo¨ffler-Mary et al., 2000). For detection of GFP.S
within the virion envelope, particles were immunoprecipi-
tated with the a-GFP MAb JL-8 that had been coated to a
10% (wt/vol) suspension of protein G-Sepharose (10-Al
antibody was bound to 100 Al Sepharose solution in an
overnight reaction at 4 8C). Immunoprecipitation was
performed in the presence of 0.5% NP-40 and precipitates
were then washed two times with TEN buffer (50 mM Tris–
HCl [pH 7.5], 1 mM EDTA, 75 mM NH4Cl). Detection of
the encapsidated viral progeny DNA by radioactive labeling
of the partially double-stranded genome with 10 ACi
[a32P]dATP (Amersham Biosciences) by the endogenous
polymerase, isolation, and separation of the DNA by
agarose gel electrophoresis have been described (Lo¨ffler-
Mary et al., 2000). The radioactive signal was detected by
PhosphorImager scanning.
For detection of HBV DNA on dot-blots, an EcoRI-
linearized unit-length HBV genome was labeled with
digoxygenin-dUTP by random priming as instructed by
the manufacturer (Roche). After extraction of the DNA
genomes from the immunoprecipitated samples as
described, they were denatured by boiling in 0.4 M
NaOH–10 mM EDTA and filtered with a dot-blot manifold
(Schleicher and Schqll) onto nylon membranes. The
membrane was baked at 120 8C for 30 min and hybridized
with the labeled probe according to the Roche DIG DNA
labeling and detection kit.
Binding assay
For binding analysis, human hepatoma HepG2 cells were
cultivated in glass bottom dishes in Dulbecco’s modified
Eagle’s medium with 10% fetal calf serum (FCS). HBV and
subviral particles secreted from HuH-7 (co)-transfected cells
were precipitated from 10-ml culture supernatant in the
presence of 6% polyethylene glycol 8000 (PEG; Sigma).
The pellet was resuspended in 200-Al phosphate-buffered
saline (PBS) containing 25% FCS. HepG2 cells wereincubated with 50 Al of this concentrate, diluted in 1 ml
culture medium with 4% PEG, for 20 h at 37 8C. Cells were
washed three times with PBS and analyzed for GFP
fluorescence by microscopy.Acknowledgments
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